A variety of factors may be at work in each case, but for humoral immunity, a recurring problem seems to be difficulty in eliciting production of antibodies that recognize the pathogen—natural ...
This engineered fidelity ensures the MEM will help select antibodies that reliably recognize the epitope of interest in its natural in vivo context. The MEM platform enables RubrYc to discover ...
9, 2025 /PRNewswire/ -- Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient ... and about 10% of ...